BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Golledge J, Ward NC, Watts GF. Lipid management in people with peripheral artery disease. Curr Opin Lipidol 2019;30:470-6. [PMID: 31577608 DOI: 10.1097/MOL.0000000000000638] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Golledge J, Rowbotham S, Velu R, Quigley F, Jenkins J, Bourke M, Bourke B, Thanigaimani S, Chan DC, Watts GF. Association of Serum Lipoprotein (a) With the Requirement for a Peripheral Artery Operation and the Incidence of Major Adverse Cardiovascular Events in People With Peripheral Artery Disease. J Am Heart Assoc 2020;9:e015355. [PMID: 32172653 DOI: 10.1161/JAHA.119.015355] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
2 Paraskevas KI, Gloviczki P, Antignani PL, Comerota AJ, Dardik A, Davies AH, Eckstein H, Faggioli G, Fernandes JFE, Fraedrich G, Geroulakos G, Golledge J, Gupta A, Gurevich VS, Jawien A, Jezovnik MK, Kakkos SK, Knoflach M, Lanza G, Liapis CD, Loftus IM, Mansilha A, Nicolaides AN, Pini R, Poredos P, Proczka RM, Ricco J, Rundek T, Saba L, Schlachetzki F, Silvestrini M, Spinelli F, Stilo F, Suri JS, Svetlikov AV, Zeebregts CJ, Chaturvedi S, Veith FJ, Mikhailidis DP. Benefits and drawbacks of statins and non-statin lipid lowering agents in carotid artery disease. Progress in Cardiovascular Diseases 2022. [DOI: 10.1016/j.pcad.2022.05.003] [Reference Citation Analysis]
3 Ward NC, Kostner KM, Sullivan DR, Nestel P, Watts GF. Molecular, Population, and Clinical Aspects of Lipoprotein(a): A Bridge Too Far? J Clin Med 2019;8:E2073. [PMID: 31783529 DOI: 10.3390/jcm8122073] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
4 Watts GF, Stroes ESG. Editorial: New targets, treatments and trials for preventing and reversing atherosclerosis: the paradox of choice. Curr Opin Lipidol 2019;30:417-8. [PMID: 31688168 DOI: 10.1097/MOL.0000000000000650] [Reference Citation Analysis]
5 Golledge J, Fernando M, Lazzarini P, Najafi B, G Armstrong D. The Potential Role of Sensors, Wearables and Telehealth in the Remote Management of Diabetes-Related Foot Disease. Sensors (Basel). 2020;20. [PMID: 32823514 DOI: 10.3390/s20164527] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
6 Ward NC, Nolde JM, Chan J, Carnagarin R, Watts GF, Schlaich MP. Lipoprotein (a) and Hypertension. Curr Hypertens Rep 2021;23:44. [PMID: 34888749 DOI: 10.1007/s11906-021-01161-6] [Reference Citation Analysis]
7 Golledge J, Drovandi A. Evidence-Based Recommendations for Medical Management of Peripheral Artery Disease. J Atheroscler Thromb 2021;28:573-83. [PMID: 33746159 DOI: 10.5551/jat.62778] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Golledge J. Update on the pathophysiology and medical treatment of peripheral artery disease. Nat Rev Cardiol 2022. [PMID: 34997200 DOI: 10.1038/s41569-021-00663-9] [Reference Citation Analysis]
9 Golledge J, Velu R, Quigley F, Jenkins J, Singh TP. Cohort Study Examining the Prevalence and Relationship with Outcome of Standard Modifiable Risk Factors in Patients with Peripheral Artery Occlusive and Aneurysmal Disease. Eur J Vasc Endovasc Surg 2021:S1078-5884(21)00823-6. [PMID: 34916106 DOI: 10.1016/j.ejvs.2021.10.039] [Reference Citation Analysis]